Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v15-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2021-01-18 | 2020-09-29 |
| Drug Identification Number | 00511226 | 00511226 |
| Brand name | TROMBOJECT 3% INJ 30MG/ML | TROMBOJECT 3% INJ 30MG/ML |
| Common or Proper name | Sodium Tetradecyl Sulfate Injection | Sodium Tetradecyl Sulfate Injection |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | SODIUM TETRADECYL SULFATE | SODIUM TETRADECYL SULFATE |
| Strength(s) | 30MG | 30MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5 x 5mL vial / fiole | 5 x 5mL vial / fiole |
| ATC code | C05BB | C05BB |
| ATC description | ANTIVARICOSE THERAPY | ANTIVARICOSE THERAPY |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2020-10-02 | 2020-10-02 |
| Actual start date | 2020-09-30 | |
| Estimated end date | 2020-12-08 | 2021-01-31 |
| Actual end date | 2021-01-08 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Manufacturing delay | Manufacturing delay |
| Health Canada comments |